APEX ACE HLDG (06036) announced its interim results, with a profit attributable to shareholders of HKD 134 million, an increase of 1149.28% year-on-year.
GloLi Technology (06036) announced its mid-term results for the six months ending June 30, 2026, reporting revenues of HK$4.973 billion, a year-on-year increase of 126.25%; the profit attributable to shareholders was HK$134 million, a year-on-year increase of 1149.28%; basic earnings per share were HK$0.1271.
APEX ACE HLDG (06036) announced its interim results for the six months ended June 30, 2026, reporting revenue of HKD 4.973 billion, an increase of 126.25% year-on-year; profit attributable to owners of the company was HKD 134 million, reflecting a year-on-year increase of 1149.28%; basic earnings per share were HKD 0.1271.
The announcement stated that the revenue growth was mainly attributed to: (i) a substantial increase in product prices, driving revenue growth in core products; (ii) timely leverage of the upward market price trend, enhancing the group's procurement and supply capabilities; and (iii) accelerated optimization of the customer structure, enabling the group to penetrate high-demand areas such as renewable energy and servers, thereby achieving both volume and price increases.
Related Articles
LUYE PHARMA (02186) is set to launch II phase clinical trials in China for its mRNA vaccine LY01620, intended for the treatment of cervical precancerous lesions and HPV-related tumors.
CHINA POWER (02380) achieved strong growth in its hydropower segment in the first half of the year, with clean energy installed capacity accounting for over 80%.
3SBIO (01530) released its mid-term results, with a net profit attributable to shareholders of 1.147 billion yuan, a decrease of 15.58% year-on-year.
LUYE PHARMA (02186) is set to launch II phase clinical trials in China for its mRNA vaccine LY01620, intended for the treatment of cervical precancerous lesions and HPV-related tumors.
CHINA POWER (02380) achieved strong growth in its hydropower segment in the first half of the year, with clean energy installed capacity accounting for over 80%.
3SBIO (01530) released its mid-term results, with a net profit attributable to shareholders of 1.147 billion yuan, a decrease of 15.58% year-on-year.
RECOMMEND
